Ravagalimab

Ravagalimab Uses, Dosage, Side Effects, Food Interaction and all others data.

Ravagalimab is under investigation in clinical trial NCT03695185 (A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe It Is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy).

Trade Name Ravagalimab
Generic Ravagalimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Ravagalimab
Ravagalimab

Innovators Monograph

You find simplified version here Ravagalimab


*** Taking medicines without doctor's advice can cause long-term problems.
Share